Gordon, M. S., Rosen, L. S., Mendelson, D., Ramanathan, R. K., Goldman, J., Liu, L., . . . Weiss, G. J. (2012). A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Invest New Drugs.
Chicago Style citaatGordon, Michael S., et al. "A Phase 1 Study of TRC102, an Inhibitor of Base Excision Repair, and Pemetrexed in Patients With Advanced Solid Tumors." Invest New Drugs 2012.
MLA citatieGordon, Michael S., et al. "A Phase 1 Study of TRC102, an Inhibitor of Base Excision Repair, and Pemetrexed in Patients With Advanced Solid Tumors." Invest New Drugs 2012.
Let op: Deze citaties zijn niet altijd 100% accuraat.